Department of Molecular Biology

Department of Molecular Biology

Massachusetts General Hospital, a Harvard Medical School teaching hospital
Upcoming Events

Events are generally limited to MGB personnel and their academic colleagues, and particularly those from our sister institutions in the greater Boston area

  • Apr
  • 24
  • 2026
Dunia Abdul-Aziz, MD. Kingston Lab:

How can we restore inner ear hair cells and hearing?

  • Apr
  • 24
  • 2026
Sam Wattus, PhD, Wattrus Lab:

Medaka and Zebrafish as twin model systems to study spinal cord injury

  • May
  • 1
  • 2026
Xiang David Li, PhD, Professor Department of Chemistry, The University of Hong Kong, China. Host: Radhika Subramanian, PhD:

Cell Biology Seminars at Harvard Medical School: Chemical Approaches to Decoding Epigenetics

  • May
  • 4
  • 2026
Yu-Chen Hsieh, Orefice Lab, at Harvard Medical School:

Dorsal root ganglion neuron dysfunction contributes to autism-related gastrointestinal deficits in mice

  • May
  • 13
  • 2026
Molecular Biology Department Chair, Faculty and Directors:

Monthy lunch to discuss daily operations, science, and more. Sign up required

  • May
  • 18
  • 2026
Michael Zhu Chen, Mootha Lab:

Tracing mitochondrial proteome evolution across the tree of life

All events
Latest News
Congratulations to Melissa Walker, MD, PhD, for the Claflin Distinguished Scholar Award from the MGH Executive Committee on Research.

Melissa was selected for her proposal “T Cell Senescence, Inflammation as Targetable Features of Genetic Mitochondrial DNA Diseases.”

Congratulations to Gary Ruvkun for the 2024 Nobel Prize in Physiology and Medicine, awarded for his co-discovery of microRNA and its role in post-transcriptional gene regulation.

MGH and Harvard Medical School investigator Gary Ruvkun, PhD, has been named a recipient of the 2024 Nobel Prize in Physiology or Medicine for his role in the discovery of microRNA and its role in post-transcriptional gene regulation. He shares the award with his collaborator Victor Ambros, PhD, of the University of Massachusetts Medical School. 

Over the past two decades, research into the potential of microRNAs for the diagnosis, prognosis and treatment of disease has expanded from the two original papers published by Ruvkun and Ambros in 1993 to 176,000 papers today. 

Nobel Ceremony Video 
Nobel Lecture 
Press Release 
Press Conference

Transitions in development — an interview with Margarete Diaz Cuadros

The Company of Biologists spoke to Margarete over Teams to learn more about her transition to becoming a group leader and her philosophy for creating a positive lab environment. 

Read More

All news